Global Specialty Generics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Generics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Injectables
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Specialty Generics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Retail Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Specialty Generics Market Size (2017-2028)
2.2 Specialty Generics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Specialty Generics Market Size by Region (2017-2022)
2.4 Global Specialty Generics Market Size Forecast by Region (2023-2028)
2.5 Global Top Specialty Generics Countries Ranking by Market Size
3 Specialty Generics Competitive by Company
3.1 Global Specialty Generics Revenue by Players
3.1.1 Global Specialty Generics Revenue by Players (2017-2022)
3.1.2 Global Specialty Generics Market Share by Players (2017-2022)
3.2 Global Specialty Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Specialty Generics Revenue
3.4 Global Specialty Generics Market Concentration Ratio
3.4.1 Global Specialty Generics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Generics Revenue in 2021
3.5 Global Specialty Generics Key Players Head office and Area Served
3.6 Key Players Specialty Generics Product Solution and Service
3.7 Date of Enter into Specialty Generics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Specialty Generics Breakdown Data by Type
4.1 Global Specialty Generics Historic Revenue by Type (2017-2022)
4.2 Global Specialty Generics Forecasted Revenue by Type (2023-2028)
5 Global Specialty Generics Breakdown Data by Application
5.1 Global Specialty Generics Historic Market Size by Application (2017-2022)
5.2 Global Specialty Generics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Specialty Generics Revenue by Company (2020-2022)
6.2 North America Specialty Generics Revenue by Type (2017-2028)
6.3 North America Specialty Generics Revenue by Application (2017-2028)
6.4 North America Specialty Generics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Specialty Generics Revenue by Company (2020-2022)
7.2 Europe Specialty Generics Revenue by Type (2017-2028)
7.3 Europe Specialty Generics Revenue by Application (2017-2028)
7.4 Europe Specialty Generics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Specialty Generics Revenue by Company (2020-2022)
8.2 Asia Pacific Specialty Generics Revenue by Type (2017-2028)
8.3 Asia Pacific Specialty Generics Revenue by Application (2017-2028)
8.4 Asia Pacific Specialty Generics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Specialty Generics Revenue by Company (2020-2022)
9.2 Latin America Specialty Generics Revenue by Type (2017-2028)
9.3 Latin America Specialty Generics Revenue by Application (2017-2028)
9.4 Latin America Specialty Generics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Specialty Generics Revenue by Company (2020-2022)
10.2 Middle East and Africa Specialty Generics Revenue by Type (2017-2028)
10.3 Middle East and Africa Specialty Generics Revenue by Application (2017-2028)
10.4 Middle East and Africa Specialty Generics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Teva Pharmaceuticals Industries
11.1.1 Teva Pharmaceuticals Industries Company Details
11.1.2 Teva Pharmaceuticals Industries Business Overview
11.1.3 Teva Pharmaceuticals Industries Specialty Generics Products and Services
11.1.4 Teva Pharmaceuticals Industries Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.1.5 Teva Pharmaceuticals Industries Specialty Generics SWOT Analysis
11.1.6 Teva Pharmaceuticals Industries Recent Developments
11.2 Akorn, Inc.
11.2.1 Akorn, Inc. Company Details
11.2.2 Akorn, Inc. Business Overview
11.2.3 Akorn, Inc. Specialty Generics Products and Services
11.2.4 Akorn, Inc. Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.2.5 Akorn, Inc. Specialty Generics SWOT Analysis
11.2.6 Akorn, Inc. Recent Developments
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Details
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Specialty Generics Products and Services
11.3.4 Mylan N.V. Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.3.5 Mylan N.V. Specialty Generics SWOT Analysis
11.3.6 Mylan N.V. Recent Developments
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Details
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Specialty Generics Products and Services
11.4.4 Mallinckrodt Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.4.5 Mallinckrodt Specialty Generics SWOT Analysis
11.4.6 Mallinckrodt Recent Developments
11.5 Sandoz International GmbH
11.5.1 Sandoz International GmbH Company Details
11.5.2 Sandoz International GmbH Business Overview
11.5.3 Sandoz International GmbH Specialty Generics Products and Services
11.5.4 Sandoz International GmbH Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.5.5 Sandoz International GmbH Specialty Generics SWOT Analysis
11.5.6 Sandoz International GmbH Recent Developments
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Company Details
11.6.2 Pfizer, Inc. Business Overview
11.6.3 Pfizer, Inc. Specialty Generics Products and Services
11.6.4 Pfizer, Inc. Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.6.5 Pfizer, Inc. Specialty Generics SWOT Analysis
11.6.6 Pfizer, Inc. Recent Developments
11.7 Sun Pharmaceutical Industries Ltd.
11.7.1 Sun Pharmaceutical Industries Ltd. Company Details
11.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.7.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Products and Services
11.7.4 Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.7.5 Sun Pharmaceutical Industries Ltd. Specialty Generics SWOT Analysis
11.7.6 Sun Pharmaceutical Industries Ltd. Recent Developments
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Company Details
11.8.2 Valeant Pharmaceuticals Business Overview
11.8.3 Valeant Pharmaceuticals Specialty Generics Products and Services
11.8.4 Valeant Pharmaceuticals Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.8.5 Valeant Pharmaceuticals Specialty Generics SWOT Analysis
11.8.6 Valeant Pharmaceuticals Recent Developments
11.9 Apotex Corp.
11.9.1 Apotex Corp. Company Details
11.9.2 Apotex Corp. Business Overview
11.9.3 Apotex Corp. Specialty Generics Products and Services
11.9.4 Apotex Corp. Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.9.5 Apotex Corp. Specialty Generics SWOT Analysis
11.9.6 Apotex Corp. Recent Developments
11.10 Endo International plc.
11.10.1 Endo International plc. Company Details
11.10.2 Endo International plc. Business Overview
11.10.3 Endo International plc. Specialty Generics Products and Services
11.10.4 Endo International plc. Specialty Generics Revenue in Specialty Generics Business (2017-2022)
11.10.5 Endo International plc. Specialty Generics SWOT Analysis
11.10.6 Endo International plc. Recent Developments
12 Specialty Generics Market Dynamics
12.1 Specialty Generics Market Trends
12.2 Specialty Generics Market Drivers
12.3 Specialty Generics Market Challenges
12.4 Specialty Generics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Specialty Generics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Injectables
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Specialty Generics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Specialty Generics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Specialty Generics Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Specialty Generics Revenue Market Share by Region (2017-2022)
Table 9. Global Specialty Generics Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Specialty Generics Market Share by Players (2017-2022)
Table 11. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2021)
Table 12. Ranking of Global Top Specialty Generics Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Specialty Generics Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Specialty Generics Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Specialty Generics Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Specialty Generics Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Specialty Generics Revenue Market Share by Type (2017-2022)
Table 20. Global Specialty Generics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Specialty Generics Revenue Market Share by Type (2023-2028)
Table 22. Global Specialty Generics Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Specialty Generics Revenue Market Share by Application (2017-2022)
Table 24. Global Specialty Generics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Specialty Generics Revenue Market Share by Application (2023-2028)
Table 26. North America Specialty Generics Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Specialty Generics Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Specialty Generics Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Specialty Generics Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Specialty Generics Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Specialty Generics Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Specialty Generics Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Specialty Generics Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Specialty Generics Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Specialty Generics Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Specialty Generics Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Specialty Generics Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Specialty Generics Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Specialty Generics Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Specialty Generics Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Specialty Generics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Specialty Generics Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Specialty Generics Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Specialty Generics Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Specialty Generics Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Specialty Generics Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Specialty Generics Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Specialty Generics Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Specialty Generics Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Specialty Generics Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Specialty Generics Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Specialty Generics Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Specialty Generics Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Specialty Generics Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Specialty Generics Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Specialty Generics Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Specialty Generics Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Specialty Generics Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Specialty Generics Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Specialty Generics Revenue by Country (2023-2028) & (US$ Million)
Table 61. Teva Pharmaceuticals Industries Company Details
Table 62. Teva Pharmaceuticals Industries Business Overview
Table 63. Teva Pharmaceuticals Industries Specialty Generics Product and Services
Table 64. Teva Pharmaceuticals Industries Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 65. Teva Pharmaceuticals Industries Specialty Generics SWOT Analysis
Table 66. Teva Pharmaceuticals Industries Recent Developments
Table 67. Akorn, Inc. Company Details
Table 68. Akorn, Inc. Business Overview
Table 69. Akorn, Inc. Specialty Generics Product and Services
Table 70. Akorn, Inc. Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 71. Akorn, Inc. Specialty Generics SWOT Analysis
Table 72. Akorn, Inc. Recent Developments
Table 73. Mylan N.V. Company Details
Table 74. Mylan N.V. Business Overview
Table 75. Mylan N.V. Specialty Generics Product and Services
Table 76. Mylan N.V. Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 77. Mylan N.V. Specialty Generics SWOT Analysis
Table 78. Mylan N.V. Recent Developments
Table 79. Mallinckrodt Company Details
Table 80. Mallinckrodt Business Overview
Table 81. Mallinckrodt Specialty Generics Product and Services
Table 82. Mallinckrodt Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 83. Mallinckrodt Specialty Generics SWOT Analysis
Table 84. Mallinckrodt Recent Developments
Table 85. Sandoz International GmbH Company Details
Table 86. Sandoz International GmbH Business Overview
Table 87. Sandoz International GmbH Specialty Generics Product and Services
Table 88. Sandoz International GmbH Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 89. Sandoz International GmbH Specialty Generics SWOT Analysis
Table 90. Sandoz International GmbH Recent Developments
Table 91. Pfizer, Inc. Company Details
Table 92. Pfizer, Inc. Business Overview
Table 93. Pfizer, Inc. Specialty Generics Product and Services
Table 94. Pfizer, Inc. Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 95. Pfizer, Inc. Specialty Generics SWOT Analysis
Table 96. Pfizer, Inc. Recent Developments
Table 97. Sun Pharmaceutical Industries Ltd. Company Details
Table 98. Sun Pharmaceutical Industries Ltd. Business Overview
Table 99. Sun Pharmaceutical Industries Ltd. Specialty Generics Product and Services
Table 100. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 101. Sun Pharmaceutical Industries Ltd. Specialty Generics SWOT Analysis
Table 102. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 103. Valeant Pharmaceuticals Company Details
Table 104. Valeant Pharmaceuticals Business Overview
Table 105. Valeant Pharmaceuticals Specialty Generics Product and Services
Table 106. Valeant Pharmaceuticals Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 107. Valeant Pharmaceuticals Specialty Generics SWOT Analysis
Table 108. Valeant Pharmaceuticals Recent Developments
Table 109. Apotex Corp. Company Details
Table 110. Apotex Corp. Business Overview
Table 111. Apotex Corp. Specialty Generics Product and Services
Table 112. Apotex Corp. Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 113. Apotex Corp. Specialty Generics SWOT Analysis
Table 114. Apotex Corp. Recent Developments
Table 115. Endo International plc. Company Details
Table 116. Endo International plc. Business Overview
Table 117. Endo International plc. Specialty Generics Product and Services
Table 118. Endo International plc. Specialty Generics Revenue in Specialty Generics Business (2017-2022) & (US$ Million)
Table 119. Endo International plc. Specialty Generics SWOT Analysis
Table 120. Endo International plc. Recent Developments
Table 121. Specialty Generics Market Trends
Table 122. Specialty Generics Market Drivers
Table 123. Specialty Generics Market Challenges
Table 124. Specialty Generics Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Specialty Generics Sales Market Share by Type: 2021 VS 2028
Figure 2. Injectables Features
Figure 3. Oral Features
Figure 4. Others Features
Figure 5. Global Specialty Generics Sales Market Share by Application: 2021 VS 2028
Figure 6. Retail Pharmacies Case Studies
Figure 7. Specialty Pharmacies Case Studies
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Specialty Generics Report Years Considered
Figure 10. Global Specialty Generics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Specialty Generics Market Size 2017-2028 (US$ Million)
Figure 12. Global Specialty Generics Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Specialty Generics Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Specialty Generics Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Specialty Generics Market Share by Players in 2021
Figure 16. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Specialty Generics Revenue in 2021
Figure 18. North America Specialty Generics Revenue Market Share by Company in 2021
Figure 19. North America Specialty Generics Revenue Market Share by Type (2017-2028)
Figure 20. North America Specialty Generics Revenue Market Share by Application (2017-2028)
Figure 21. North America Specialty Generics Revenue Share by Country (2017-2028)
Figure 22. U.S. Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Specialty Generics Revenue Market Share by Company in 2021
Figure 25. Europe Specialty Generics Revenue Market Share by Type (2017-2028)
Figure 26. Europe Specialty Generics Revenue Market Share by Application (2017-2028)
Figure 27. Europe Specialty Generics Revenue Share by Country (2017-2028)
Figure 28. Germany Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 29. France Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Specialty Generics Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Specialty Generics Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Specialty Generics Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Specialty Generics Revenue Share by Region (2017-2028)
Figure 37. China Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 40. India Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Specialty Generics Revenue Market Share by Company in 2021
Figure 49. Latin America Specialty Generics Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Specialty Generics Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Specialty Generics Revenue Share by Country (2017-2028)
Figure 52. Mexico Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Specialty Generics Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Specialty Generics Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Specialty Generics Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Specialty Generics Revenue Share by Country (2017-2028)
Figure 59. Turkey Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Specialty Generics Revenue (2017-2028) & (US$ Million)
Figure 62. Teva Pharmaceuticals Industries Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 63. Akorn, Inc. Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 64. Mylan N.V. Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 65. Mallinckrodt Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 66. Sandoz International GmbH Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 67. Pfizer, Inc. Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 68. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 69. Valeant Pharmaceuticals Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 70. Apotex Corp. Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 71. Endo International plc. Revenue Growth Rate in Specialty Generics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed